Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial

1

The IBD-BOOST trial randomized 780 participants with inflammatory bowel disease to assess a digital self-management intervention for pain, fatigue, and faecal incontinence.
2

The intervention did not significantly improve primary outcomes but showed trends towards benefits in secondary health economic measures.
3

Participants in the IBD-BOOST group gained an additional 0.016 quality-adjusted life years (QALYs) over 12 months compared to the control group.
4

The IBD-BOOST intervention resulted in cost savings of £304.66 for healthcare and £39.48 for out-of-pocket expenses per participant.
5

The analysis indicated high probability of cost-effectiveness for the IBD-BOOST intervention from both health services and societal perspectives.

Bmj Open Gastroenterology

by Chris Roukas, Laura Miller, Fionn Cléirigh Büttner, Thomas Hamborg, Vladimir Sergeevich Gordeev, Vari Wileman, Richard C G Pollok, Sonia Saxena, Rona Moss-Morris, Ailsa Hart, James O Lindsay, Christine Norton, Borislava Mihaylova
July 1, 2026

1